283 related articles for article (PubMed ID: 31482490)
1. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells.
Lee HM; Kim DH; Lee HL; Cha B; Kang DH; Jeong YI
Arch Pharm Res; 2019 Nov; 42(11):990-999. PubMed ID: 31482490
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Ca
Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
[TBL] [Abstract][Full Text] [Related]
4. Chlorin e6 Conjugated Methoxy-Poly(Ethylene Glycol)-Poly(D,L-Lactide) Glutathione Sensitive Micelles for Photodynamic Therapy.
Kumari P; Paul M; Bhatt H; Rompicharla SVK; Sarkar D; Ghosh B; Biswas S
Pharm Res; 2020 Jan; 37(2):18. PubMed ID: 31897768
[TBL] [Abstract][Full Text] [Related]
5. Construction of multifunctional mesoporous silicon nano-drug delivery system and study of dual sensitization of chemo-photodynamic therapy in vitro and in vivo.
Xu J; Zhang J; Song J; Liu Y; Li J; Wang X; Tang R
J Colloid Interface Sci; 2022 Dec; 628(Pt B):271-285. PubMed ID: 35998453
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
7. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.
Cuperus R; van Kuilenburg AB; Leen R; Bras J; Caron HN; Tytgat GA
Free Radic Biol Med; 2011 Sep; 51(6):1213-20. PubMed ID: 21741474
[TBL] [Abstract][Full Text] [Related]
8. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
9. Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway.
Chowdhury AA; Chaudhuri J; Biswas N; Manna A; Chatterjee S; Mahato SK; Chaudhuri U; Jaisankar P; Bandyopadhyay S
PLoS One; 2013; 8(9):e73672. PubMed ID: 24040019
[TBL] [Abstract][Full Text] [Related]
10. The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.
Tagde A; Singh H; Kang MH; Reynolds CP
Blood Cancer J; 2014 Jul; 4(7):e229. PubMed ID: 25036800
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.
Jiang F; Lilge L; Belcuig M; Singh G; Grenier J; Li Y; Chopp M
Lasers Surg Med; 1998; 23(3):161-6. PubMed ID: 9779650
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma.
Palomares T; Bilbao P; del Olmo M; Castro B; Calle Y; Alonso-Varona A
Melanoma Res; 1999 Jun; 9(3):233-42. PubMed ID: 10465578
[TBL] [Abstract][Full Text] [Related]
14. Defensive mechanism in cholangiocarcinoma cells against oxidative stress induced by chlorin e6-based photodynamic therapy.
Lee HM; Chung CW; Kim CH; Kim DH; Kwak TW; Jeong YI; Kang DH
Drug Des Devel Ther; 2014; 8():1451-62. PubMed ID: 25258513
[TBL] [Abstract][Full Text] [Related]
15. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
[TBL] [Abstract][Full Text] [Related]
16. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound enhances the efficacy of chlorin E6-mediated photodynamic therapy in MDA-MB-231 cells.
Wang H; Wang X; Wang P; Zhang K; Yang S; Liu Q
Ultrasound Med Biol; 2013 Sep; 39(9):1713-24. PubMed ID: 23830103
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
Chen G; Zeller WJ
Anticancer Res; 1991; 11(6):2231-7. PubMed ID: 1776864
[TBL] [Abstract][Full Text] [Related]
19. The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO).
Chen J; Small-Howard A; Yin A; Berry MJ
BMC Neurosci; 2005 Feb; 6():10. PubMed ID: 15707499
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W
Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
